ResMed: Home Tests for Sleep Apnea Detection Could Increase Diagnoses Among 1 Billion Affected People!
Reading Time: 2 minutes
The medical technology company ResMed (RMD) is a global leader in facial interfaces in the field of sleep and respiratory health. It primarily supplies PAP ventilation devices, masks, accessories, and software solutions for the treatment of patients with sleep apnea. An estimated 1 billion people worldwide are affected, with 80% of cases remaining undiagnosed. Smartwatches from Apple, Samsung, or Garmin are already helping to detect signs. However, diagnoses could also increase due to the home test "NightOwl," introduced in the USA on April 3rd....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
